SEC Comment Letter 0000000000-23-009259 to Yo-Health Inc. (CIK 0001844793)
Yo-Health Inc. (CIK 0001844793)
Date: Aug. 23, 2023 · CIK: 0001844793 · Accession: 0000000000-23-009259
AI Filing Summary & Sentiment
Letter
United States securities and exchange commission logo August 23, 2023 Peter Thawnghmung Chief Executive Officer Yo-Health Inc. 990 Gerry Avenue Lido Beach, NY 11561 Re:Yo-Health Inc. Form 10-K for the fiscal year ended December 31, 2022 Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2022 File No. 0-56521 Dear Peter Thawnghmung: We issued comments to you on the above captioned filing on June 20, 2023. As of the date of this letter, these comments remain outstanding and unresolved. We expect you to provide a complete, substantive response to these comments by September 6, 2023. If you do not respond, we will, consistent with our obligations under the federal securities laws, decide how we will seek to resolve material outstanding comments and complete our review of your filings and your disclosure. Among other things, we may decide to release publicly, through the agency's EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff's decision to publicly release comment and response letters relating to disclosure filings it has reviewed. You may contact Charles Eastman at (202) 551-3794 or Jean Yu at (202) 551-3305 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing
Show Raw Text
United States securities and exchange commission logo
August 23, 2023
Peter Thawnghmung
Chief Executive Officer
Yo-Health Inc.
990 Gerry Avenue
Lido Beach, NY 11561
Re:Yo-Health Inc.
Form 10-K for the fiscal year ended December 31, 2022
Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2022
File No. 0-56521
Dear Peter Thawnghmung:
We issued comments to you on the above captioned filing on June 20, 2023. As of the
date of this letter, these comments remain outstanding and unresolved. We expect you to
provide a complete, substantive response to these comments by September 6, 2023.
If you do not respond, we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our
review of your filings and your disclosure. Among other things, we may decide to release
publicly, through the agency's EDGAR system, all correspondence, including this letter, relating
to the review of your filings, consistent with the staff's decision to publicly release comment and
response letters relating to disclosure filings it has reviewed.
You may contact Charles Eastman at (202) 551-3794 or Jean Yu at (202) 551-3305 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing